European Union Trademark No. 002144046 (Word) Trademark register: EUIPO Status: registered

 
Word mark

ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM
The European Union Trademark for ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM (Word) was filed on 22.03.2001 for goods and services in class(es) 1, 5 and 42 at the European Union Intellectual Property Office (EUIPO). The current status of the trademark No. 002144046 ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM is 'registered'.


 
Trademark information
NameULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM
TypeWord
RegisterEuropean Union Intellectual Property Office (EUIPO)
 
Filing date22.03.2001
Registration date19.03.2003
Expiry date22.03.2021
 
Nice classes1, 5 and 42
OwnerMedarex, Inc.
 08540 Princeton,, New Jersey, US
 
RepresentativeJACOBACCI & PARTNERS S.P.A.
 10152 Torino, IT
 
Goods and Services (the trademark is registered for the following goods and services)
Class 1 : Chemicals used in industry and science; biochemicals; biochemicals being monoclonal antibodies for in vitro or scientific research regarding cancer, acquired immune deficiency syndrome (AIDS) and other infectious diseases, autoimmune diseases and cardiovascular diseases.
Class 5 : Pharmaceutical preparations for use in the treatment of cancer, acquired immune deficiency syndrome (AIDS) and other infectious diseases, auto immune diseases, and cardiovascular diseases; monoclonal antibody therapeutic preparations for use in the treatment of cancer, acquired immune deficiency syndrome (AIDS) and other infectious diseases, auto immune diseases, and cardiovascular diseases.
Class 42 : Medical, hygienic and beauty care services, scientific and industrial research services; medical and pharmaceutical research services; research, development and production of human antibodies; consultancy, advisory and research services relating to the aforesaid services.
 
tmdb is a free trademark search website of publicly available records. tmdb does not guarantee nor warrant the accuracy, completeness or timeliness of the data.